APA Цитирование

Jiang, T., Xu, X., Chen, X., Ding, N., Hu, Q., Zhou, C., & Hu, J. (2020). Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases. Transl Lung Cancer Res.

Chicago-стиль цитирования

Jiang, Tao, Xiaobo Xu, Xiaojuan Chen, Ning Ding, Qin Hu, Caicun Zhou, and Jie Hu. "Osimertinib in Combination With Bevacizumab in EGFR-Mutated NSCLC With Leptomeningeal Metastases." Transl Lung Cancer Res 2020.

MLA-цитирование

Jiang, Tao, et al. "Osimertinib in Combination With Bevacizumab in EGFR-Mutated NSCLC With Leptomeningeal Metastases." Transl Lung Cancer Res 2020.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.